In this golden autumn of October, the Metanotitia team attended the BIO-EUROPE 2022 Conference. It was held in Leipzig, Germany on October 24-26, 2022, with a virtual conference on November 2-4.
As one of the benchmark conferences in the biotechnology industry, BIO-Europe aims to promote the development of the global biotechnology industry and expand biotechnology innovation. The conference attracted more than 2,200 biotechnology companies from more than 60 countries including the United States, Britain, Germany, France, and China.
The Metanotitia team met one-on-one with global biopharmaceutical companies and experts in related research fields, including business leaders, investors, and pharmaceutical R&D institutions. Metanotitia, a global leader in metabolomics technology, shared its experience and achievements in metabolomics application in cancer biomarker development at this meeting. The discussion and communication with thousands of biotechnology leaders and innovators from around the world established new cooperation and partnerships, which is expected to push cutting-edge metabolomics technology to the broad market to solve the key challenge to global health problems.
At the following week post BIO-Europe, the Metanotitia team attended the ChinaBio virtual forum held on November 8-11. The conference brought together KOLs of biotechnology and pharmaceutical industry leaders from all over the world and Chinese biotech companies.
